SJS Investment Consulting’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
SJS Investment Consulting's RCKT Position: Q3 2026 in Review
SJS Investment Consulting increased its Rocket Pharmaceuticals (RCKT) stake by 111% in Q3 2026, buying an estimated $1.84K and bringing the position to 1,008 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.
SJS Investment Consulting first reported a position in RCKT in Q1 2026 and has held it in 3 quarters since. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- SJS Investment Consulting held 1,008 shares of Rocket Pharmaceuticals worth $2.65K as of Q3 2026.
- SJS Investment Consulting bought 531 Rocket Pharmaceuticals shares in Q3 2026, an estimated $1.84K.
- Rocket Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2083 holding.
- SJS Investment Consulting first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.